Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. north america
  4. melanoma
Show results for
Products
Services
Software
Training
Applications

Companies


Refine by
Locations
Back to All Locations

  • North America
  • U.S. Virgin Islands
Brands

  • medchemexpress
  • xoft axxent
  • sensus healthcare
  • xstrahl
  • cytomx
View all brands
Applications

  • Diagnostic Solutions for Lung Cancer
  • Liquid Biopsy Solutions for Breast Cancer
  • Diagnostic Solutions for Colorectal Cancer

Melanoma Equipment Supplied In North America

165 equipment items found
In North AmericaAvailable In North AmericaNear North America

DecisionDx - Melanoma

DecisionDx - Melanoma

by:Castle Biosciences, Inc.   based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Recurrence or Metastasis: DecisionDx-Melanoma was designed to address the need for a more accurate predictor of metastatic risk in patients diagnosed with cutaneous (skin) melanoma. ...
CONTACT SUPPLIER

myPath and DiffDx - Melanoma Gene Expression Profile (GEP) Tests

myPath and DiffDx - Melanoma Gene Expression Profile (GEP) Tests

by:Castle Biosciences, Inc.   based inFriendswood, TEXAS (USA)
Increased Clarity for Difficult-to-Diagnose Melanocytic Lesions. MyPath Melanoma and DecisionDx DiffDx Melanoma gene expression profile (GEP) tests are designed to provide objective information to aid in the diagnosis and inform management decisions for patients with ambiguous melanocytic ...
CONTACT SUPPLIER

DecisionDx-CMSeq - Next-generation Sequencing for Cutaneous Melanoma

DecisionDx-CMSeq - Next-generation Sequencing for Cutaneous Melanoma

by:Castle Biosciences, Inc.   based inFriendswood, TEXAS (USA)
Our DecisionDx-CMSeq is a 3-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to cutaneous melanoma in melanoma tumor tissue. The test includes hotspot mutations in the genes BRAF, NRAS and ...
CONTACT SUPPLIER

DecisionDx-UMSeq - Next-Generation Sequencing for Uveal Melanoma

DecisionDx-UMSeq - Next-Generation Sequencing for Uveal Melanoma

by:Castle Biosciences, Inc.   based inFriendswood, TEXAS (USA)
Our DecisionDx-UMSeq is a 7-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to uveal melanoma. Researchers believe that identifying mutations in tumor genes may someday help guide treatment decisions. Because the amount of tumor biopsy tissue is limited, it is important to gain as much information as possible about a uveal ...
CONTACT SUPPLIER

DecisionDx-UM - Standard of Care for Predicting Metastatic Risk in Uveal Melanoma

DecisionDx-UM - Standard of Care for Predicting Metastatic Risk in Uveal Melanoma

by:Castle Biosciences, Inc.   based inFriendswood, TEXAS (USA)
Uveal melanoma, commonly known as ocular or choroidal melanoma, is a rare cancer of the eye with approximately 2,000 patients diagnosed annually in the U.S. At the time of initial diagnosis, approximately 97% of patients are free of metastasis. ...
CONTACT SUPPLIER

Model Skin eBx - Non-Surgical Non-Melanoma Skin Cancer Treatment

Model Skin eBx - Non-Surgical Non-Melanoma Skin Cancer Treatment

Manufactured by:Xoft, Inc.   based inSan Jose, CALIFORNIA (USA)
With the Xoft System, painless, scar-free treatment of NMSC is possible with skin eBx, a form of high dose rate, low energy radiation therapy delivered in minutes over a short series of office visits. While Mohs surgery is considered to be the standard of care for non-melanoma skin cancer (NMSC) treatment, for some patients, surgery is not an option or a ...
CONTACT SUPPLIER

TriStar - Model TA3126 - IO Multi Tumor Array 3 of a set of 6 TMAs : Sarcoma, GIST, Gallbladder, Head & Neck SCC, Melanoma, GBM, Thyroid with histopath data

TriStar - Model TA3126 - IO Multi Tumor Array 3 of a set of 6 TMAs : Sarcoma, GIST, Gallbladder, Head & Neck SCC, Melanoma, GBM, Thyroid with histopath data

Manufactured by:TriStar Technology Group LLC   based inWashington, DISTRICT OF COLUMBIA (USA)
Molecular Data: Yes; Approx. # of Donors: 72; Follow Up Data: No; Cores per Donor: 2; Core Size: 1mm; Approx. # of Cores *: 144; TA number: TA3126; List of markers: CD3, CD4, CD8, CD20, CD68, CD163, FOXP3, PD1, PD-L1(22C3); Suitable for (IHC or RNA-ISH): IHC; Suitable for CODEX/GeoMx/CosMx: ...
CONTACT SUPPLIER

DecisionDx-PRAME - Gene Expression Profile Testing

DecisionDx-PRAME - Gene Expression Profile Testing

by:Castle Biosciences, Inc.   based inFriendswood, TEXAS (USA)
Castle Biosciences offers DecisionDx-PRAME gene expression profile testing to assess expression of the PRAME (preferentially expressed antigen in melanoma) gene. DecisionDx-PRAME is an optional, additional test that can be run on the same sample as your DecisionDx®-UM GEP (gene expression profile) test. ...
CONTACT SUPPLIER

CytomX - Model BMS-986249 - CTLA-4 - Directed Probody Therapeutic

CytomX - Model BMS-986249 - CTLA-4 - Directed Probody Therapeutic

Manufactured by:CytomX Therapeutics, Inc.   based inSouth San Francisco, CALIFORNIA (USA)
Bristol Myers Squibb initiated a Phase 2 randomized 5-arm cohort expansion study in its ongoing first-in-human Phase 1/2a trial of the anti-CTLA-4 Probody BMS-986249, a Probody version of the anti-CTLA-4 antibody Yervoy® (ipilimumab), in combination with Opdivo® (nivolumab) in patients with metastatic melanoma ...
CONTACT SUPPLIER

ALL Chemistry Inc. - Model SRIP11557 - RIPK1-IN-7

ALL Chemistry Inc. - Model SRIP11557 - RIPK1-IN-7

Manufactured by:ALL Chemistry Inc.   based inMarlton, NEW JERSEY (USA)
RIPK1-IN-7 is a potent and selective inhibitor of RIPK1(Kd of 4 nM and an enzymatic IC50 of 11 nM),andexhibits excellent antimetastasis activity in the experimental B16 melanoma lung metastasis ...
CONTACT SUPPLIER

Model RGN3118 - Anti-Cancer for Microtubule Targeting Agent

Model RGN3118 - Anti-Cancer for Microtubule Targeting Agent

Manufactured by:Reglagene Holding, Inc.   based inTucson, ARIZONA (USA)
RGN3118 is a potent, orally administered, blood-brain barrier penetrant therapy that has been optimized for the treatment of high-grade gliomas, such as glioblastoma as well as brain metastases from breast, lung, and melanoma cancers. ...
CONTACT SUPPLIER

Biocept - Model BRAF V600E - Target Selector Mutation Test Kit

Biocept - Model BRAF V600E - Target Selector Mutation Test Kit

Manufactured by:Biocept    based inSan Diego, CALIFORNIA (USA)
his kit detects BRAF V600 mutations in DNA derived from blood plasma or FFPE tissue sections to give insight into cancer characteristics and provide Biomarker status of tumors such as ...
CONTACT SUPPLIER

Axl-IN-7

Axl-IN-7

by:Alfa Cytology   based inU.S. VIRGIN ISLANDS
Axl-IN-7 (Chemie 22) is a potent AXL inhibitor. Axl-IN-7 can be used to study Axl-related diseases, such as cancer (such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer and glioma), kidney disease, immune system disease and cardiovascular disease. ...
CONTACT SUPPLIER

CytomX - Model CX-072 - PD-L1 - Targeting Probody Therapeutic

CytomX - Model CX-072 - PD-L1 - Targeting Probody Therapeutic

Manufactured by:CytomX Therapeutics, Inc.   based inSouth San Francisco, CALIFORNIA (USA)
Following a recent program and portfolio prioritization, CytomX has also made the strategic decision to terminate the Phase 2 trial of the anti-PD-L1 Probody CX-072 in combination with Yervoy® (ipilimumab) in melanoma. This allows CytomX to focus on its potential first-in-class assets, including the combination of CX-072 and CX-2009. ...
CONTACT SUPPLIER

Sensus Healthcare - Model SRT-100+ - A State-Of-The Art System.

Sensus Healthcare - Model SRT-100+ - A State-Of-The Art System.

by:Sensus Healthcare, Inc.   based inBoca Raton, FLORIDA (USA)
The SRT-100+™—a state-of-the art system that is transforming the lives of people coping with non-melanoma skin cancer and unsightly keloid scars has been developed by Sensus ...
CONTACT SUPPLIER

Model TK-8001 - TCR-T Targeting MAGE-A1 Positive Solid Tumors

Model TK-8001 - TCR-T Targeting MAGE-A1 Positive Solid Tumors

Manufactured by:T-Knife GmbH   based inBerlin, GERMANY
TK-8001 is a CD8 TCR-T specific for the Melanoma-associated Antigen Gene-A1, or MAGE-A1. MAGE-A1 is associated with hallmarks of aggressive cancers and poor clinical prognosis, and there is an emerging body of evidence indicating its involvement as a potential driver of tumorigenesis. ...
CONTACT SUPPLIER

Paclitaxel - Active Pharmaceutical Ingredient

Paclitaxel - Active Pharmaceutical Ingredient

Manufactured by:Phyton Biotech Ltd   based inDelta, BRITISH COLUMBIA (CANADA)
Paclitaxel (sold under trade name Taxol® by Bristol-Myers Squibb) is a very effective plant-derived chemotherapy drug used to treat breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumor cancers. It has also been used to treat Kaposi’s sarcoma. ...
CONTACT SUPPLIER

GeneAb - Model IHC505 - Actin, Muscle Specific Antibody

GeneAb - Model IHC505 - Actin, Muscle Specific Antibody

Manufactured by:GenomeMe Lab Inc.   based inRichmond, BRITISH COLUMBIA (CANADA)
Skeletal, smooth, and cardiac muscle cells will all stain positively with Anti-Muscle Specific Actin, but mesenchymal cells, not including myoepithelium, will stain negatively. Normal and neoplastic non-muscle cells, including vascular endothelial and connective tissues, carcinomas, melanomas, and lymphomas, will also be negative for muscle specific actin. The use of Anti-Muscle ...
CONTACT SUPPLIER

Model Lumio 2 - Lumio Scopes

Model Lumio 2 - Lumio Scopes

Manufactured by:DermLite LLC   based inSan Juan Capistrano, CALIFORNIA (USA)
Or, select its Wood mode, a special blend custom-tailored to resemble the unique illumination of a Wood's lamp which may help with evaluating the borders and extent of lentigo maligna as well as melanoma excision scars for signs of recurrence, among others. ...
CONTACT SUPPLIER

Xoft Axxent - Model SPX - Controller for Electronic Brachytherapy

Xoft Axxent - Model SPX - Controller for Electronic Brachytherapy

Manufactured by:Xoft, Inc.   based inSan Jose, CALIFORNIA (USA)
Xoft offers patients and physicians a non-invasive alternative to surgery for non-melanoma skin cancer (NMSC) treatment. With the Xoft Axxent Electronic Brachytherapy (eBx) System, painless, scar-free treatment of NMSC is possible with skin eBx, a form of high dose rate, low energy radiation therapy. The Axxent SPX controller is a key component of the skin eBx platform ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT